The toxic effects of cigarette additives. Philip Morris' project mix reconsidered: an analysis of documents released through litigation.
In 2009, the promulgation of US Food and Drug Administration (FDA) tobacco regulation focused attention on cigarette flavor additives. The tobacco industry had prepared for this eventuality by initiating a research program focusing on additive toxicity. The objective of this study was to analyze Phi...
Main Authors: | Marcia S Wertz, Thomas Kyriss, Suman Paranjape, Stanton A Glantz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-12-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3243707?pdf=render |
Similar Items
-
Philip Morris' litigation prevention program in Asia
by: Sungkyu Lee, et al.
Published: (2018-03-01) -
Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
by: Crystal E Tan, et al.
Published: (2013-01-01) -
Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations.
by: Clayton Velicer, et al.
Published: (2015-01-01) -
Metrology at Philip Morris Europe
by: Gualandris R, et al.
Published: (2014-12-01) -
Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.
by: Jesse Elias, et al.
Published: (2018-05-01)